文献速递生殖医学

减数分裂重组:机制及其在人类生殖中的作用,特别关注非梗阻性无精子症

Meiotic recombination: insights into its mechanisms and its role in human reproduction with a special focus on non-obstructive azoospermia.
PubMed 文献 · Hum Reprod Update · 2022-01-01

本综述检索2016年1月至2022年2月PubMed文献,最终纳入271篇,概述减数分裂重组的分子机制及相关人类不育症,重点为非梗阻性无精子症(NOA)。至少26个减数分裂重组相关基因在男性NOA中报道突变,其中10个也在女性早发性卵巢功能不全(POI)中突变。作者建议可开发基因panel筛查不育个体,NOA患者携带明确致病突变时不应推荐睾丸取精。

要点

  • 减数分裂重组相关基因突变可导致配子发生失败,引起亚生育或不育。
  • 至少26个减数分裂重组相关基因在男性NOA中报道突变,其中10个在女性POI中突变。
  • 作者建议可开发减数分裂重组相关基因panel筛查不育个体。

核心结论

  • 减数分裂重组相关基因变异可导致人类亚生育或不育,尤其是NOA。
  • 理解同源染色体配对、重组和及时分离过程可为分析人类亚生育或不育的潜在单基因病因及开发个体化治疗提供指导。

研究设计与样本

  • 本综述为文献综述,检索PubMed数据库,主要关注2016年1月至2022年2月间发表的英文文献。
  • 检索词「meiosis」与减数分裂起始、染色体配对、同源重组、染色体轴、DSB、DSB修复、交叉、减数分裂性染色体失活、减数分裂检查点、减数分裂停滞、NOA、POI或卵巢早衰、治疗和癌症等关键词组合。
  • 初步检索产生约3500条记录,多数为会议摘要或重复、非英文文本或数据不足而被剔除,最终纳入271篇与减数分裂重组相关的文章。

主要发现

  • 综述概述了减数分裂重组过程中的分子和机制,包括减数分裂特异性染色体结构、DSB形成、同源搜索、重组中间体形成和交叉形成。
  • 累积结果表明减数分裂由一系列减数分裂重组基因和蛋白质顺序调控。
  • 这些基因的突变常影响减数分裂进程,激活减数分裂检查点,导致生殖细胞停滞,引起亚生育或不育。
  • 至少26个减数分裂重组相关基因在男性NOA中报道突变,其中10个基因在女性POI中突变。

关键数值与推荐

  • 至少26个减数分裂重组相关基因在男性NOA中报道突变。
  • 其中10个基因在女性POI中突变。

临床怎么用

  • 作者认为,在临床实践中可开发减数分裂重组相关基因panel以筛查亚生育或不育个体的基因突变。
  • 作者认为,当NOA患者携带明确的减数分裂基因致病突变时,不应推荐睾丸取精,以避免不必要的侵入性诊断。
  • 作者认为,若女性携带减数分裂重组相关基因突变,应评估卵巢功能障碍风险。
  • 作者认为,未来可能通过操控减数分裂重组相关基因来改善或恢复生育力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meiosis is an essential stage in the life cycle of sexually reproducing species, underlying formation of haploid gametes and serving as the basis of genetic diversity. A central mechanism of meiosis is recombination between homologous chromosomes, during which programmed DNA double-strand breaks (DSBs) are sequentially repaired to form the crossovers essential for faithful chromosomal segregation. Aberrant meiotic recombination often leads to gametogenic failure or produces aneuploid gametes resulting in subfertility or infertility, miscarriage or birth defects. OBJECTIVE AND RATIONALE: The goal of this review was to characterize the molecular mechanisms of meiotic recombination and related human infertility disorders, particularly male infertility caused by non-obstructive azoospermia (NOA). SEARCH METHODS: Our search included PubMed database articles, focusing mainly on English-language publications dated between January 2016 and February 2022. The search term 'meiosis' was combined with the following keywords: meiotic initiation, chromosome pairing, homologous recombination, chromosome axis, DSB, DSB repair, crossover, meiotic sex chromosome inactivation, meiotic checkpoints, meiotic arrest, NOA, premature ovarian insufficiency (POI) or premature ovarian failure, treatment and cancer. In addition, references within these articles were used to identify additional studies. OUTCOMES: The preliminary search generated ∼3500 records. The majority of articles were identified as meeting abstracts or duplicates, contained non-English text or provided insufficient data and were therefore eliminated. A total of 271 articles associated with meiotic recombination were included in the final analysis. This review provides an overview of molecules and mechanisms involved in meiotic recombination processes, specifically meiosis-specific chromosome structures, DSB formation, homology search, formation of recombination intermediates and crossover formation. The cumulative results suggest that meiosis is regulated sequentially by a series of meiotic recombination genes and proteins. Importantly, mutations in these genes often affect meiotic progression, activating meiotic checkpoints, causing germ cell arrest and leading to subfertility or infertility. At least 26 meiotic recombination-related genes have been reported to be mutated in NOA in men, and 10 of these genes are mutated in POI in women. This suggests that variants of meiotic recombination-related genes can cause human subfertility or infertility, especially NOA. WIDER IMPLICATIONS: Understanding the processes of homologous chromosome pairing, recombination and timely resolution of homologous chromosomes may provide guidance for the analysis of potential monogenetic causes of human subfertility or infertility and the development of personalized treatments. In clinical practice, we can develop a meiotic recombination-related gene panel to screen for gene mutations in individuals with subfertility or infertility. Testicular sperm extraction should not be recommended when an NOA-affected individual carries definite disease-causing mutations of a meiotic gene, so as to avoid the unnecessary invasive diagnosis. Risk of ovarian dysfunction should be evaluated if a woman carries meiotic recombination-related gene mutations. It may be possible to improve or restore fertility through manipulation of meiotic recombination-related genes in the future.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Xie C, Wang W, Tu C, et al. Meiotic recombination: insights into its mechanisms and its role in human reproduction with a special focus on non-obstructive azoospermia. Hum Reprod Update. 2022. PMID: 35613017. doi:10.1093/humupd/dmac024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。